| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4621 | 2020 |
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with … FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... European heart journal 42 (34), 3227-3337, 2021 | 4346 | 2021 |
| ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular … Authors/Task Force Members, L Rydén, PJ Grant, SD Anker, C Berne, ... European heart journal 34 (39), 3035-3087, 2013 | 2401 | 2013 |
| † Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text‡: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology … L Ryden, E Standl, M Bartnik, GV Berghe, J Betteridge, MJ De Boer, ... European heart journal supplements 9 (suppl_C), C3-C74, 2007 | 2211 | 2007 |
| Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I MA Creager, TF Lüscher, prepared with the assistance of, F Cosentino, ... Circulation 108 (12), 1527-1532, 2003 | 1929 | 2003 |
| ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal … Endorsed by: the European Stroke Organisation (ESO), ... European heart journal 32 (22), 2851-2906, 2011 | 1646 | 2011 |
| Cardiovascular outcomes with ertugliflozin in type 2 diabetes CP Cannon, R Pratley, S Dagogo-Jack, J Mancuso, S Huyck, ... New England Journal of Medicine 383 (15), 1425-1435, 2020 | 1287 | 2020 |
| The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed … C Vlachopoulos, P Xaplanteris, V Aboyans, M Brodmann, R Cífková, ... Atherosclerosis 241 (2), 507-532, 2015 | 874 | 2015 |
| Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis DK McGuire, WJ Shih, F Cosentino, B Charbonnel, DZI Cherney, ... JAMA cardiology 6 (2), 148-158, 2021 | 813 | 2021 |
| Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. E Stroes, J Kastelein, F Cosentino, W Erkelens, R Wever, H Koomans, ... The Journal of clinical investigation 99 (1), 41-46, 1997 | 757 | 1997 |
| Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II TF Lüscher, MA Creager, JA Beckman, F Cosentino Circulation 108 (13), 1655-1661, 2003 | 714 | 2003 |
| Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology PM Seferović, MC Petrie, GS Filippatos, SD Anker, G Rosano, ... European journal of heart failure 20 (5), 853-872, 2018 | 665 | 2018 |
| Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways M Eto, T Kozai, F Cosentino, H Joch, TF Lüscher Circulation 105 (15), 1756-1759, 2002 | 503 | 2002 |
| Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. F Cosentino, S Patton, LV d'Uscio, ER Werner, G Werner-Felmayer, ... The Journal of clinical investigation 101 (7), 1530-1537, 1998 | 468 | 1998 |
| Ageing, metabolism and cardiovascular disease S Costantino, F Paneni, F Cosentino The Journal of physiology 594 (8), 2061-2073, 2016 | 455 | 2016 |
| Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II JA Beckman, F Paneni, F Cosentino, MA Creager European heart journal 34 (31), 2444-2452, 2013 | 443 | 2013 |
| Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation J Lekakis, P Abraham, A Balbarini, A Blann, CM Boulanger, J Cockcroft, ... European Journal of Cardiovascular Prevention & Rehabilitation 18 (6), 775-789, 2011 | 422 | 2011 |
| Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial … A Fagotti, G Ferrandina, G Vizzielli, F Fanfani, V Gallotta, V Chiantera, ... European journal of cancer 59, 22-33, 2016 | 380 | 2016 |
| Endothelial dysfunction in diabetes mellitus. F Cosentino, TF Lüscher Journal of cardiovascular pharmacology 32, S54-61, 1998 | 372 | 1998 |
| Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. MR Tschudi, M Barton, NA Bersinger, P Moreau, F Cosentino, G Noll, ... The Journal of clinical investigation 98 (4), 899-905, 1996 | 350 | 1996 |
